First experience in proteasome inhibitor therapy of dedifferentiated, radioiodine negative, somatostatin- receptor negative thyroid cancer

被引：0
|
作者：
Putzer, Daniel [1 ]
Gabriel, Michael [1 ]
Eisterer, Wolfgang [2 ]
Kendler, Dorota [1 ]
Prommegger, Rupert [3 ]
Madleitner, Ruth [1 ]
Dobrozemsky, Georg [1 ]
Gastl, Guenther [2 ]
Virgolini, Irene [1 ]
机构：
[1] Innsbruck Med Univ, Dept Nucl Med, Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria
[3] Innsbruck Med Univ, Dept Surg, Innsbruck, Austria
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1667
引用
收藏
页数：2
相关论文
共 50 条
  • [1] First experience in proteasome inhibitor therapy of dedifferentiated, radioiodine negative, SSTR negative thyroid cancer
    Putzer, D.
    Gabriel, M.
    Eisterer, W.
    Kendler, D.
    Prommegger, R.
    Dobrozemsky, G.
    Gastl, G.
    Virgolini, I. J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S215 - S215
  • [2] Experimental peptide receptor radionuclide therapy in radioiodine negative somatostatin receptor positive thyroid cancer
    Nilica, B.
    Kroiss, A.
    Putzer, D.
    Uprimny, C.
    Warwitz, B.
    Kendler, D.
    Waitz, D.
    Virgolini, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S125 - S125
  • [3] First Experience With Proteasome Inhibitor Treatment of Radioiodine Nonavid Thyroid Cancer Using Bortezomib
    Putzer, Daniel
    Gabriel, Micheal
    Kroiss, Alexander
    Madleitner, Ruth
    Eisterer, Wolfgang
    Kendler, Dorota
    Uprimny, Christian
    Bale, Reto J.
    Gastl, Guenther
    Virgolini, Irene J.
    [J]. CLINICAL NUCLEAR MEDICINE, 2012, 37 (06) : 539 - 544
  • [4] Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience
    Damle, Nishikant
    Patnecha, Manish
    Kumar, Praveen
    Maharjan, Sagar
    Bal, Chandrasekhar
    [J]. INDIAN JOURNAL OF NUCLEAR MEDICINE, 2011, 26 (03): : 144 - 148
  • [5] Thyroglobulin-positive, radioiodine-negative thyroid cancer
    Gemsenjäger, E
    [J]. THYROID, 2003, 13 (08) : 833 - 834
  • [6] Thyroglobulin-positive, radioiodine-negative thyroid cancer
    Levy, EG
    [J]. THYROID, 2001, 11 (06) : 599 - 602
  • [7] Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy
    Valli, N
    Catargi, B
    Ronci, N
    Leccia, F
    Guyot, M
    Roger, P
    Ducassou, D
    Tabarin, A
    [J]. THYROID, 1999, 9 (06) : 583 - 589
  • [8] Innumerable Radioiodine Negative Cutaneous Metastases From Papillary Thyroid Cancer
    Damle, Nishikant A.
    Ramya, Soundararajan
    Singh, Harmandeep
    Durgapal, Prashant
    Bal, Chandrasekhar
    Mathur, Sandeep
    Kumar, Praveen
    [J]. JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 1 (05) : 227 - 231
  • [9] 18F-FDG PET for the monitoring of a redifferentiation therapy of radioiodine negative thyroid cancer.
    Menzel, C
    Diehl, M
    Döbert, N
    Graichen, S
    Hamscho, N
    Berner, U
    Grünwald, F
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05): : 322P - 322P
  • [10] Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
    Chung, June-Key
    Cheon, Gi Jeong
    [J]. ENDOCRINOLOGY AND METABOLISM, 2014, 29 (03) : 233 - 239
12345